Medical - Devices · NYSE
Precio Actual
$84.51
VENTAJA COMPETITIVA
↑Extensive Product Portfolio and Brand Recognition
Abbott's diverse medical device and diagnostics offerings create switching costs. Strong brand reputation fosters customer loyalty and physician preference.
↑Innovation and R&D Investment
Consistent investment in research and development fuels new product launches. This maintains a competitive edge in rapidly evolving medical technology.
↑Global Distribution Network and Scale
Abbott's established global presence provides access to diverse markets. Scale allows for efficient manufacturing and cost advantages.
RIESGOS DE INVERSIÓN
↓Regulatory Scrutiny and Product Recalls
The medical device industry faces strict regulatory oversight. Product recalls can damage reputation and impact financial performance.
↓Competition from Established and Emerging Players
Abbott faces competition from large, established companies and innovative startups. Pricing pressures and market share erosion are possible.
↓Patent Expiration and Generic Competition
Loss of patent protection on key products can lead to generic competition. This can significantly reduce revenue and profitability.
Combina los insights de IA con la valoración DCF o PE para calcular el valor intrínseco. Toma mejores decisiones de valoración con datos.
Esta página proporciona insights de valoración con IA para Abbott Laboratories (ABT), incluyendo ventaja competitiva y factores de riesgo de inversión. La valoración es central para decisiones de inversión sólidas — usa las herramientas de valoración DCF y PE de MiniValuator junto con estos insights de IA para calcular el valor intrínseco de ABT, el margen de seguridad, y llegar a una valoración bien fundamentada.
